drugset / Trial / NCT07140640

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

NCT07140640 ↗

Phase 4 Not yet recruiting 333 enrolled Aswan University
NaFactorialOpen-labelPrevention

Summary

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

Timeline

Start
2025-09-15
Primary completion
2026-03-15
Completion
2026-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 10 mg Intrathecal
Comparator Bupivacaine Other / unclassified 12.5 mg Intrathecal
Comparator Fentanyl Other / unclassified 25 ug Intrathecal

Indications

No indication recorded.